Juno Therapeutics

Juno Therapeutics is an American tumor immunotherapy developer that primarily provides users with chimeric antigen receptor T-cell immunotherapy (CAR-T) and TCT cell therapy, applied in the treatment of hematological malignancies such as acute lymphoblastic leukemia and non-Hodgkin lymphoma.